Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-109800
Filing Date
2016-03-21
Accepted
2016-03-21 17:03:47
Documents
1
Period of Report
2016-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3984
  Complete submission text file 0001209191-16-109800.txt   5402
Mailing Address C/O IMMUNOGEN, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
JUNIUS DANIEL M (Reporting) CIK: 0001094159 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0627
Type: 4 | Act: 34 | File No.: 001-36177 | Film No.: 161519244

Mailing Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations